10-Q: eHealth Reports Q3 2025 Loss Improvement Amid Medicare Shifts

eHealth, Inc. reported an improved net loss for the third quarter and first nine months of 2025, driven by cost reductions and higher net adjustment revenue, despite declines in total approved members across key segments.

Summary

• Net loss for the three months ended September 30, 2025, improved to $(31.7) million from $(42.5) million in the prior year period.
• Net loss for the nine months ended September 30, 2025, improved to $(47.1) million from $(87.4) million in the prior year period.
• Total revenue for the three months ended September 30, 2025, decreased by 8% to $53.9 million, primarily due to a 35% decrease in other revenue (sponsorship and advertising).
• Total revenue for the nine months ended September 30, 2025, increased by 5% to $227.8 million, driven by an 8% increase in commission revenue.
• Commission revenue for the nine months ended September 30, 2025, increased by $14.9 million (8%) to $200.9 million, largely due to a significant increase in net adjustment revenue from prior periods' enrollments ($39.1 million in 2025 vs. $12.8 million in 2024).
• Total approved members declined by 21% in the three months ended September 30, 2025, and 3% for the nine months ended September 30, 2025.
• Medicare Advantage approved members decreased by 29% in the three months ended September 30, 2025, attributed to intentionally decreased variable marketing spend in response to 2025 regulatory changes impacting dual-eligible beneficiaries.
• Estimated total membership declined by 4% year-over-year to 1,118,521 as of September 30, 2025.
• Cash and cash equivalents increased to $63.1 million as of September 30, 2025, from $39.2 million at December 31, 2024.
• Net cash provided by operating activities for the nine months ended September 30, 2025, was $10.6 million, up from $9.3 million in the prior year.
• The company remains non-compliant with certain covenants of its convertible preferred stock agreement (Asset Coverage Ratio since September 30, 2023, and Minimum Liquidity Amount since November 30, 2024), granting the investor additional rights.
• The term loan credit agreement maturity date was extended from February 2026 to January 2027.

Sentiment

Score: 6

Explanation: The company demonstrated improved profitability and cash flow generation despite a challenging regulatory environment that impacted member acquisition in certain segments. Strategic adjustments, including a flexible telesales structure and AI integration, are promising. However, declines in approved members and ongoing covenant non-compliance with the preferred stock investor present headwinds, leading to a neutral to slightly positive outlook.

Positives

• Net loss improved for both the three months (by $10.8 million) and nine months (by $40.3 million) ended September 30, 2025, compared to the prior year, indicating better financial management.
• Total revenue for the nine months ended September 30, 2025, increased by 5% to $227.8 million.
• Commission revenue for the nine months ended September 30, 2025, increased by 8% to $200.9 million.
• Net adjustment revenue from prior periods' enrollments significantly increased to $39.1 million for the nine months ended September 30, 2025, compared to $12.8 million in the prior year.
• Medicare segment gross profit increased by 70% to $53.7 million for the nine months ended September 30, 2025.
• Medicare Supplement constrained Lifetime Value (LTV) per approved member increased by 33% in Q3 2025 due to favorable carrier/contract mix, retention assumptions, and a decreased constraint.
• Net cash provided by operating activities increased to $10.6 million for the nine months ended September 30, 2025, from $9.3 million in the prior year.
• Net cash provided by investing activities significantly improved to $19.0 million for the nine months ended September 30, 2025, from a $56.4 million use in the prior year.
• Cash and cash equivalents increased to $63.1 million as of September 30, 2025, from $39.2 million at December 31, 2024.
• The company successfully adjusted to regulatory changes by implementing a more flexible telesales organization structure.
• Achieved benefit advisor hiring and training goals for the 2026 Annual Enrollment Period (AEP), with a more tenured advisor mix.
• Integrated artificial intelligence (AI) across several components of the telephonic enrollment platform to assist beneficiaries and reduce wait times.
• The term loan credit agreement maturity was extended to January 2027, and the company was in compliance with its loan covenants as of September 30, 2025.
• The One Big Beautiful Bill Act (OBBBA) was signed into law on July 4, 2025, making 100% bonus depreciation and domestic R&D expensing permanent.

Negatives

• Total revenue decreased by 8% in the three months ended September 30, 2025, primarily due to a $2.7 million decrease in sponsorship and advertising revenue.
• Total approved members declined by 21% in Q3 2025 and 3% for the nine months ended September 30, 2025.
• Medicare Advantage approved members decreased by 29% in Q3 2025 due to intentionally decreased variable marketing spend in response to 2025 regulatory changes.
• Individual and Family plan approved members declined by 35% in Q3 2025 and 28% for the nine months ended September 30, 2025.
• Medicare Part D constrained LTV per approved member decreased by 24% in Q3 2025 due to unfavorable carrier and contract mix.
• Qualified Health Plans constrained LTV per approved member decreased by 14% in Q3 2025 due to an increased constraint and unfavorable retention/carrier mix.
• Estimated total membership declined by 4% year-over-year to 1,118,521 as of September 30, 2025.
• Medicare Customer Care and Enrollment (CC&E) cost per MA-equivalent approved member increased by 29% in Q3 2025.
• Employer and Individual (E&I) segment gross profit decreased by 47% in Q3 2025 and 48% for the nine months ended September 30, 2025.
• Retained earnings (accumulated deficit) shifted from a positive $15.2 million at December 31, 2024, to a deficit of $(43.8) million at September 30, 2025.
• The company is non-compliant with the Minimum Asset Coverage Ratio since September 30, 2023, and the Minimum Liquidity Amount since November 30, 2024, under its convertible preferred stock agreement.
• Ongoing legal proceedings related to alleged Federal False Claims Act violations pose a potential liability.
• Interest income decreased by $2.5 million for the nine months ended September 30, 2025, due to less favorable short-term investment returns and lower average balances.

Risks

• The markets in which the company participates are intensely competitive, including competition from government-run health insurance exchanges and marketplaces.
• The business may be harmed if relationships with health insurance carriers are lost or modified, or if a significant portion of revenue from a small number of carriers is impaired.
• Inability to successfully attract and convert qualified prospects into members for whom commissions are received would harm the business.
• The business, operating results, and financial condition will be adversely impacted if the company is unable to retain existing members.
• Marketing efforts may not be successful or may become more expensive, adversely affecting the business.
• If the carrier advertising and sponsorship program is not successful, the business could be harmed.
• Operations in China involve many risks, including political/geopolitical issues, changes in laws, carrier inquiries, and intellectual property protection, which could increase expenses and liability.
• The business is seasonal in nature, and failure to respond to changes in seasonality could harm the business.
• Changes in senior management or other key employees could affect the business.
• The business success depends on the ability to timely recruit, train, and retain qualified licensed insurance agents (benefit advisors) and other personnel while controlling labor costs.
• The business could be harmed if the company is not successful in executing on its operational and strategic plans.
• Self-insurance programs may expose the company to significant and unexpected costs and losses.
• Changes and developments in the health insurance industry or system, including changes in laws and regulations (e.g., Medicare-for-All proposals, CMS rules), could harm the business.
• Non-compliance with or changes in complex and frequently changing laws, regulations, and guidelines related to marketing and sale of health insurance plans could harm the business.
• The company has been and may in the future be subject to various legal proceedings, including litigation, government enforcement actions, or regulatory inquiries (e.g., Federal False Claims Act lawsuit).
• Inability to operate the business if health insurance licenses are not maintained or if there is non-compliance with applicable laws.
• Increasing regulatory focus on privacy and data security issues and expanding laws could impact the business and expose it to increased liability.
• The business could be harmed if the company is unable to contact consumers or market products through specific channels (email, telephone, SMS text) due to evolving laws or technology.
• Any legal liability, regulatory penalties, complaints, or negative publicity related to the company or its services could harm the business.
• Commission revenue could be negatively impacted by changes in conversion rates (approved to paying members).
• Operating results will be impacted by factors affecting the estimate of constrained Lifetime Value (LTV) of commissions per approved member (e.g., conversion rates, plan duration, commission rates, constraints).
• Inaccurate or untimely commission reports from carriers could harm the business and operating results.
• Difficulty in determining membership cancellations directly from carriers makes it hard to assess retention and accurately estimate membership.
• Agreements with the lender and convertible preferred stock investor contain restrictions (covenants, H.I.G. rights) that impact the business and expose it to risks, potentially affecting liquidity and financial condition.
• Operating and growing the business is likely to require additional capital, and if unavailable or on unacceptable terms, the business may suffer.
• Future operating results are likely to fluctuate and could fall short of guidance, negatively affecting common stock value.
• The price of common stock has been and may continue to be volatile.
• The convertible preferred stock investor (H.I.G.) has preferential rights and influence, potentially differing from common stockholders' interests and making acquisition more difficult.
• Inability to adequately protect intellectual property could harm the business.
• The business, operating results, and financial condition can be impacted by political events, political instability, trade and other international disputes, geopolitical tensions, or natural disasters.
• Adverse economic conditions including slow growth, recession, high unemployment, inflation, financial and credit market disruptions, could materially adversely affect the business.
• The company's bylaws designate a state or federal court located within the State of Delaware as the exclusive forum for substantially all disputes between the company and its stockholders, which could limit stockholders' ability to choose the judicial forum.

Future Outlook

The company expects another dynamic Annual Enrollment Period (AEP) for 2026, presenting an opportunity to drive strong consumer demand, and plans to focus on preserving its existing book of business through continued retention efforts. It will continue to invest in maintaining brand identity and anticipates seasonal trends in marketing and advertising expenses. The company expects media platforms for direct channel marketing to become increasingly expensive due to market competition. Future capital requirements will depend on enrollment volume, membership, retention rates, telesales conversion rates, and investment levels in technology, marketing, and customer care. The company may seek to raise additional capital through debt and/or equity financing to pursue strategic initiatives or make investments. The Medicare market is expected to remain fluid, with potential for new CMS rules to impact operations. The company believes its current cash, cash equivalents, short-term marketable securities, and expected cash collections will be sufficient to fund operations for at least 12 months after the filing date.

Management Comments

• Our 2025 growth strategy is focused on the scaling of our core Medicare Advantage business and pursuing revenue diversification initiatives, evolving our brand awareness across all products and enrollment channels, and improving member retention on our platform while continuing to evolve our telesales organization, advancing our digital technology leadership, and strengthening and expanding health insurance carrier partnerships.
• During the second and third quarters of 2025, Medicare enrollment volume was lower compared to the same periods in 2024, which was consistent with our expectations.
• We successfully adjusted to this regulatory change by implementing a more flexible structure in our telesales organization, making it more agile and easier to flex advisor capacity up and down in alignment with anticipated enrollment volumes.
• We expect to experience another dynamic AEP which will present an opportunity to drive strong consumer demand to our platform as beneficiaries face significant plan changes from Medicare Advantage insurance carriers.
• At the same time, we plan to focus on preserving our existing book of business through our continued retention efforts.
• We have achieved our benefit advisor hiring and training goals with a benefit advisor mix that is more tenured relative to last year and have continued to strengthen and expand our brand-driven marketing strategy, including integrating our brand message throughout our omni-channel platform.
• We have also integrated artificial intelligence (AI) across several components of our telephonic enrollment platform, enabling us to utilize AI in assisting beneficiaries during the AEP.
• Additionally, we are focusing on facilitating seamless transitions between our online and telephonic environments and have continued to expand our customer service and retention team to further improve the overall consumer experience.
• Enrollment volume in our Employer and Individual (E&I) segment continued to decline during the third quarter of 2025 due to shifts in our marketing channel mix and market conditions.
• As part of our diversification efforts, we continue to focus on supporting growth and enhancements for Individual Coverage Health Reimbursement Arrangement (ICHRA) opportunities.
• Our management, including our chief executive officer and chief financial officer, believes that our disclosure controls and our internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level.

Industry Context

The health insurance industry is intensely competitive and subject to evolving distribution models, regulatory standards, and consumer price sensitivity. The Medicare sector is undergoing changes, including a shift towards market consolidation, focus on enrollment quality, profitability, and longer-term member relationships, partly due to regulatory changes and higher medical costs. Recent regulatory changes by the U.S. Centers for Medicare & Medicaid Services (CMS) removed special enrollment periods for dual-eligible and LIS beneficiaries, impacting Medicare Advantage enrollments in Q2 and Q3 2025. The 'One Big Beautiful Bill Act' (OBBBA) signed into law on July 4, 2025, made permanent key elements of the Tax Cuts and Jobs Act, including 100% bonus depreciation, domestic research cost expensing, and business interest expense limitation. There is increased competition from national telesales insurance brokers and direct marketing by health insurance carriers. The industry also faces growing regulatory focus on privacy and data security issues, with new laws being passed at state and federal levels, and the increasing use of new technologies like artificial intelligence (AI) is influencing business operations and regulatory development.

Management Changes

Corporate Governance

Legal Proceedings

• A qui tam action, United States ex rel. Andrew Shea v. eHealth, Inc. et al, was unsealed on May 1, 2025, alleging violations of the Federal False Claims Act related to Medicare Advantage enrollment and marketing activities.
• The U.S. Attorney's Office for the District of Massachusetts filed a Complaint in Partial Intervention in this action.
• A motion to stay the Relator's claims was granted on August 15, 2025, until January 21, 2026.
• eHealth jointly filed two motions to dismiss all claims against it on August 19, 2025, with a hearing set for January 21, 2026.
• The government filed oppositions to the motions to dismiss on October 20, 2025.
• The Relator's complaint seeks treble damages, civil penalties, and costs.

Related Party Transactions

• The company has an investment agreement with Echelon Health SPV, LP (H.I.G.), the holder of its Series A convertible preferred stock. H.I.G. has liquidation preference, dividend rights, redemption rights, and conversion price adjustments.
• The H.I.G. Investment Agreement entitles H.I.G. to nominate one individual for election to the Board of Directors as long as it owns at least 30% of the common stock issuable or issued upon conversion of the Series A Preferred Stock.
• Due to non-compliance with the Minimum Asset Coverage Ratio (since Sep 30, 2023) and Minimum Liquidity Amount (since Nov 30, 2024), H.I.G. is entitled to additional rights, including nominating an additional board member, approving the annual budget, and approving hiring/termination of key executives and certain indebtedness.
• Following Aaron Tolson's resignation from the Board on September 17, 2025, H.I.G. nominated Todd Arden to the Board and Mr. Tolson as a board observer.
• The company must obtain H.I.G.'s consent to incur certain indebtedness, which could limit its ability to obtain additional financing.

Stakeholder Impact

• Shareholders: Potential dilution from equity incentive plans and future capital raises. Influence of convertible preferred stock investor (H.I.G.) due to covenant non-compliance. Volatility in stock price.
• Employees: Impacted by restructuring initiatives (employee termination benefits). Flexible telesales structure affects advisor capacity. New CEO and management changes.
• Customers (Beneficiaries): Impacted by regulatory changes affecting enrollment options (e.g., dual-eligible beneficiaries). Improved customer experience initiatives (AI, expanded retention team).
• Health Insurance Carriers: Relationships are critical for revenue. Impacted by changes in commission rates, product offerings, and regulatory compliance. Increased scrutiny on broker performance.
• Creditors (Lenders): Term loan maturity extended, company in compliance with covenants.
• Regulatory Authorities: Ongoing legal proceedings and inquiries from CMS and state departments of insurance.

Next Steps

• Focus on preserving the existing book of business through continued retention efforts.
• Drive strong consumer demand to the platform during the 2026 Annual Enrollment Period (AEP).
• Continue to strengthen and expand brand-driven marketing strategy.
• Continue to integrate artificial intelligence (AI) across the telephonic enrollment platform.
• Facilitate seamless transitions between online and telephonic environments.
• Expand customer service and retention team.
• Focus on supporting growth and enhancements for Individual Coverage Health Reimbursement Arrangement (ICHRA) opportunities.
• Address the qui tam action, including the hearing on motions to dismiss scheduled for January 21, 2026.
• Evaluate the impact of adopting new accounting pronouncements (ASU 2023-09, ASU 2024-03, ASU 2025-06).
• Potentially raise additional capital through debt and/or equity financing to fund future activities or strategic initiatives.

Key Dates

Recommendation

While the company shows improved net loss and operating cash flow, indicating better cost management and financial stability, several significant headwinds persist. Declining approved members, especially in the core Medicare Advantage segment due to regulatory changes, and the Employer and Individual segment, raise concerns about future revenue growth. The ongoing non-compliance with preferred stock covenants and the Federal False Claims Act lawsuit introduce considerable uncertainty and potential liabilities. The extension of the term loan maturity and compliance with its covenants are positive for liquidity, but the high interest rate (11.46%) is a drag. The strategic initiatives, including AI integration and a flexible telesales model, are promising but their full impact is yet to be seen. Given the mixed signals, a 'Hold' recommendation is appropriate, suggesting investors maintain their current position while monitoring the resolution of legal and governance issues and the effectiveness of growth strategies.

Keywords

Health Insurance Marketplace, Medicare Advantage, Medicare Supplement, Medicare Part D, Individual and Family Plans, Ancillary Health Products, Insurance Broker, SEC Filing, Financial Results, Commission Revenue, Approved Members, Lifetime Value of Commissions, Regulatory Changes, Healthcare Industry, Corporate Governance, Legal Proceedings, Artificial Intelligence in Healthcare, Debt Financing, Convertible Preferred Stock, Risk Factors, 10-Q